Themen

Domoscio Acquisition

Rise Up Elevates Personalised Learning Capabilities

Paris (F), May 2024 - Rise Up, one of Europe's leading integrated learning solutions - with more than five million active learners globally - has announced its strategic acquisition of Domoscio, a French expert in adaptive learning. This acquisition is set to significantly shake up the learning and HR tech landscape.

» MORE

eLearning Experts

Which Is the Better Authoring Tool, FLOWSPARKS or Articulate Rise?

Birmingham (UK), December 2022 - Let us set the scene: you've been tasked with producing learning content for your organisation, and you don't have the budget to outsource the job. You're not a professional eLearning developer, but have a good understanding of your company and capacity to produce content in house.

» MORE

DevLearn

GuyKat to Launch FLOWSPARKS in US Market

London (UK), September 2022 - GuyKat's Tampa-based US team will launch the content authoring tool FLOWSPARKS to the US market in October at DevLearn, Las Vegas's leading learning technologies event. This follows a successful launch in the UK earlier this year.

» MORE

Strategic Acquisition

100% of Virtual College Is Acquired by Netex

Carlos Ezquerro, CEO of NetexIlkley (UK), January 2022 - "We are delighted to announce that Virtual College has reached an agreement with Netex, a Spanish technology company specialising in eLearning solutions and listed on the Spanish BME stock market, for them to acquire all the shares in Virtual College." Hannah Brindle, MD, of Virtual College commented, "The entire Virtual College Team is hugely excited about our collaboration with Netex."

» MORE

eCom USA Learning Solutions

Cloud-Based VR Authoring Tool with xAPI Capability Launched

Dunfermline (SCT), March 2021 - Digital learning and assessment specialists eCom have launched a virtual reality (VR) authoring tool specifically designed for use in learning and assessment. Called eNetReality™, the tool has been successfully tested in the fields of education, construction, and medicine - and is continuing to be trialled by a pilot group of organisations in the academic, charity, and public sectors.

» MORE